Medical Cannabis for PTSD: Efficacy Review
✦ New CED Clinical Relevance #50 Clinical Context Background information relevant to the evolving cannabis medicine landscape. Mental HealthResearchSafetyAgingAnxietySleepPain Why This Matters Clinicians treating older PTSD patients need evidence…
Kentucky to end patients bringing medical marijuana from out of state
✦ New CED Clinical Relevance #52 Clinical Context Background information relevant to the evolving cannabis medicine landscape. PolicySafetyIndustryPainAnxietyMental HealthNeurology Why This Matters This regulation matters because it creates legal…
Harvard Neuroscientist Warns Federal Court: Marijuana Rescheduling May Carry …
✦ New CED Clinical Relevance #52 Clinical Context Background information relevant to the evolving cannabis medicine landscape. NeurologyPolicyResearchMental HealthSafetyPediatricsTHC Why This Matters Clinicians need to understand this evidence…
In the Mix: 39 More Articles — June 16, 2026
39 cannabis articles scored below the CED clinical relevance threshold in the last 24 hours. Summaries and source links included.
A large-scale cannabis study is launching in the canton of St. Gallen | blue News
✦ New CED Clinical Relevance #52 Clinical Context Background information relevant to the evolving cannabis medicine landscape. PolicyResearchSafetyHempCBDTHCIndustry Why This Matters This large-scale Swiss study will generate rigorous…
Swiss canton St. Gallen launches new large-scale cannabis study – SWI swissinfo.ch
✦ New CED Clinical Relevance #52 Clinical Context Background information relevant to the evolving cannabis medicine landscape. PolicyResearchHempSafetyMental HealthAnxietyNeurology Why This Matters Swiss large-scale cannabis studies provide…
Federal Science Agency Adds New Cannabis Compounds To Its Library Of ‘Chemical Fingerprints’
✦ New CED Clinical Relevance #52 Clinical Context Background information relevant to the evolving cannabis medicine landscape. ResearchHempCBDTHCSafetyIndustryPolicy Why This Matters Understanding the chemical fingerprints of cannabis compounds…
Cannabis Flower Reimbursement: Bundestag Votes on Insurance Coverage Cuts
✦ New CED Clinical Relevance #52 Clinical Context Background information relevant to the evolving cannabis medicine landscape. PolicyResearchPainTHCCBDSafetyIndustry Why This Matters German policymakers are debating whether to eliminate insurance…
Cannabis firm High Tide climbs 21% on record Q2 revenue
✦ New CED Clinical Relevance #52 Clinical Context Background information relevant to the evolving cannabis medicine landscape. IndustryMental HealthResearchPolicySafetyCBDTHC Why This Matters Clinicians treating psychiatric patients need robust…
Congressional Researchers Call Out FDA For Missing Deadline To Publish Cannabinoid …
✦ New CED Clinical Relevance #52 Clinical Context Background information relevant to the evolving cannabis medicine landscape. PolicyResearchIndustrySafetyPainAnxietyMental Health Clinical Summary Congressional researchers have criticized the FDA…